Issue 2, 2016

Targeting anti-apoptotic Bcl2 proteins with scyllatoxin-based BH3 domain mimetics

Abstract

BH3 domain mimetics based on the small protein scyllatoxin (ScTx) were designed to target the anti-apoptotic protein Bcl2 in vitro. Intrinsically disordered ScTx variants were found to bind Bcl2 with nanomolar affinity, indicating that an induced fit binding mechanism is required for favorable BH3 : Bcl2 interaction.

Graphical abstract: Targeting anti-apoptotic Bcl2 proteins with scyllatoxin-based BH3 domain mimetics

Supplementary files

Article information

Article type
Communication
Submitted
08 Oct 2015
Accepted
05 Nov 2015
First published
05 Nov 2015

Org. Biomol. Chem., 2016,14, 440-446

Author version available

Targeting anti-apoptotic Bcl2 proteins with scyllatoxin-based BH3 domain mimetics

M. M. Harris, Z. Coon, N. Alqaeisoom, B. Swords and J. M. Holub, Org. Biomol. Chem., 2016, 14, 440 DOI: 10.1039/C5OB02080H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements